The COVID-19 pandemic has had dire effects on both public health and the economy. In reaction to the virus’s spread, many states have implemented stay‐at‐home orders and closures of all “nonessential businesses.” National lockdowns have been mandated all over Europe.
Join this panel of experts for an online event that answers a broad range of questions about economic implications of such a widespread lockdown.
FEATURING:
John Cochrane, Senior Fellow at the Hoover Institution, Stanford University, Adjunct Scholar at the Cato Institute
Anna Scherbina, Associate Professor of Finance, Brandeis University
Emil Verner, Assistant Professor of Finance, Massachusetts Institute of Technology
Simon Mongey, Assistant Professor of Economics, University of Chicago
Moderated by Ryan Bourne, R. Evan Scharf Chair for the Public Understanding of Economics, Cato Institute.
Chloroquine, hydoxychloroquine, and other drugs haven't gone through the FDA approval process for treatment against Coronavirus yet. It is important, however, for people to know that clinicians are not prohibited from prescribing these drugs now.
